Prelude Capital Management, LLC Cara Therapeutics, Inc. Transaction History
Prelude Capital Management, LLC
- $1.57 Billion
- Q3 2024
Shares
4 transactions
Others Institutions Holding CARA
# of Institutions
74Shares Held
12.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.25MShares$629,6950.0% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$476,5900.06% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$435,7500.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.11MShares$311,6520.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.11MShares$310,5000.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $15M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...